Cardiovascular Disease
Siemens Healthcare Diagnostics is committed to providing a comprehensive range of diagnostic solutions for Cardiovascular Disease (CVD) management throughout the continuum of disease. This commitment represents one of several core diagnostic areas in which Siemens has pursued excellence over the years.
Our commitment to providing comprehensive CVD solutions has led to a history of innovation in reagents and instrument systems, including the introduction of the first mass CK-MB assay, the first automated cardiac Troponin-I (cTn-I) and BNP assays, and the first high sensitivity Troponin I assays*.
Siemens was also the first clinical diagnostics company to offer
- integrated cardiac methods with routine chemistries - Dimension® integrated systems
- high quality laboratory performance in the near-patient setting - Stratus® CS Acute™ Care Diagnostic System.
- a choice in Natriuretic Peptide testing – BNP or NT-proBNP
Below is an overview of our portfolio for cardiovascular disease management.
Immunoassay/Integrated/Chemistry Systems
Our portfolio of immunoassay, integrated, and chemistry systems offers a comprehensive menu of cardiac markers for risk assessment, acute care, and management.
Immunoassay Systems
Integrated Systems
Clinical Chemistry Systems
Point-of-Care Systems
The Stratus® CS Acute™ Care Diagnostic System is a model of cost effectiveness and efficiency for both your laboratory and the near-patient setting. The system offers the first FDA-cleared high sensitivity troponin I assay* with the low end precision to meet the 2005 ACC/AHA practice guidelines.
Stratus® CS Acute™ Care Diagnostic System
Plasma Protein Systems
We provide customers with a choice of analyzers using state-of-the-art nephelometry for Cardiac determination.
BN™ II System
BN ProSpec® System
Educational Information
*Defined by the ESC/ACC committee as an imprecision level of ≤10% at the 99th percentile of normal.
